Fig 1.
Diagnostic outcomes of 772 thyroid nodules with Bethesda category III cytology.
f/u, follow-up; US, ultrasound; FNA, fine needle aspiration.
Table 1.
Comparison of Malignancy Rates, Clinical and Ultrasonographic Features between Direct Surgery and Repeat FNA Groups.
Table 2.
Comparison of Malignancy Rates, Clinical and Ultrasonographic Features between Initial and Repeat Bethesda Category III Groups.
Table 3.
Clinical and Ultrasonographic Characteristics of Repeat Bethesda Category III Nodules.
Table 4.
Multivariate Analysis of Clinical and Ultrasonographic Characteristics for Predicting Malignancy of Repeat Bethesda Category III Nodules.